Table 1.
Parameter | Criterion |
---|---|
Population | Adult humans from all health backgrounds |
Intervention | Rare sugars (allulose, L-arabinose, D-tagatose, trehalose, or isomaltulose) |
Comparison |
Common sugars (sucrose, glucose, maltose, or fructose) Another rare sugar No sugar |
Outcomes | Cardiometabolic and physiological risk factors |
Study design |
Acute (post-prandial studies) trials Longer-term (≥1 week duration) trials Included randomized, non-randomized, and uncontrolled human feeding trials |